\n\n\n\n\t\t\n\t\t\tMetabolex\n\t\t\thttp://www.metabolex.com/\n\t\t
\n\t\t\n\t\t\tWatch Company\n\t\t\tGet Widget\n\t\t
\n\tMetabolex is a privately held company founded to discover and develop therapeutics for diabetes. The company\'s lead product, MBX-102, is a novel insulin sensitizer currently in Phase I clinical...More»
\n\t\t\tMetabolex is a privately held company founded to discover and develop therapeutics for diabetes. The company\'s lead product, MBX-102, is a novel insulin sensitizer currently in Phase I clinical trials. Metabolex\'s pipeline includes one product candidate in preclinical development, and three other programs optimizing lead drug candidates, one of which is partnered with Abbott Laboratories. Metabolex\'s two drug target discovery programs have produced one of the world\'s largest databases of diabetes-expressed genes. One of these programs, in insulin secretion, is partnered with Pfizer, Inc., and the other, in insulin resistance, is partnered with Yamanouchi Pharmaceuticals Co., Ltd.«Less
\n\n\t\t\tOverview
\n\t\t\t\tLocation: \tHayward, CA, United States\n
\n\t\t\t\tIndustry: Biopharmaceuticals
\n\t\t\t\tTags:\n\t\t\t\tbiotech,\n\t\t\t\ttherapeutics,\n\t\t\t\tdrugs,\n\t\t\t\tmedical,\n\t\t\t\tmedicine,\n\t\t\t\ttreatment,\n\t\t\t\tHealthcare,\n\t\t\t\tmetabolex,\n\t\t\t\tdiabetes\n\t\t\t\t
\n\t\t\tFinancials
\n\t\t\t\tLatest Funding: Series D - $32M (04/19/2007)
\n\t\t\t\tInvestors:\n\t\t\t\t\t\n\t\tAllianceBernstein,\n\t\t\t\t\t\n\t\tAlta Partners,\n\t\t\t\t\t\n\t\tBay City Capital,\n\t\t\t\t\t\n\t\tBiotech Turnaround Fund BV,\n\t\t\t\t\t\n\t\tBirchmere Ventures,\n\t\t\t\t\t\n\t\tCharter Life Sciences,\n\t\t\t\t\t\n\t\tCIBC World Markets,\n\t\t\t\t\t\n\t\tHancock Venture Partners,\n\t\t\t\t\t\n\t\tMerlin BioMed Group,\n\t\t\t\t\t\n\t\tMPM BioEquities,\n\t\t\t\t\t\n\t\tT. Rowe Price,\n\t\t\t\t\t\n\t\tVantagePoint Venture Partners,\n\t\t\t\t\t\n\t\tVenrock Associates,\n\t\t\t\t\t\n\t\tVersant Ventures,\n\t\t\t\t\t\n\t\tWanger Asset Management,\n\t\t\t\t\t\n\t\tAbbott Laboratories,\n\t\t\t\t\t\n\t\tKBC Bank & Insurance Group,\n\t\t\t\t\t\n\t\tNovo A/S,\n\t\t\t\t\t\n\t\tPfizer\n\t\t\t\t
\n\t\t\tMarket
\n\n\t\t\t\tRelated Companies:\n\t\t\t\t\tNuon Therapeutics,\n\t\t\t\t\tCapnia,\n\t\t\t\t\tNeose Technologies,\n\t\t\t\t\tSynosia Therapeutics,\n\t\t\t\t\tCelera Diagnostics,\n\t\t\t\t\tEsperion Therapeutics,\n\t\t\t\t\tMicrus Endovascular,\n\t\t\t\t\tMeritage Pharma,\n\t\t\t\t\tOptherion,\n\t\t\t\t\tTandem Diabetes Care\n\t\t\t\t
\n\t\t\tRecent News
\n\t\t\t\t\n\t\t\t\t\tNov 6, 2009\n\t\t\t\t\tMetabolex Nabs $8.6M More\n\t\t\t\t
\n\t\t\t